V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190003480 | 190000542 | null | null | null | null | 2017-02-17 | Dox + HD Mtx (post PAM) | null | null | CAP + RT | 100648254 |
| 190003497 | 190000544 | null | null | null | null | 2018-04-12 | Carboplatin + Etoposide iv&po | null | null | CARBOPLATIN + ETOPOSIDE | 101490870 |
| 190003501 | 190000545 | null | null | null | 2019-10-03 | 2019-10-05 | EW EuroEwing 2012 Arm B VDC | 02 | null | EW EUROEWING 2012 ARM B VDC | 100663666 |
| 190003507 | 190000546 | null | null | null | null | 2019-05-03 | Cisplatin + Gemcitabine (D 1 & 8) | null | null | CISPLATIN + GEMCITABINE | 101115997 |
| 190003530 | 190000547 | null | null | null | null | 2017-04-16 | Cisplatin 100 + RT(H&N) 1 day | null | null | CISPLATIN | 101566088 |
| 190003534 | 190000549 | null | null | null | null | 2018-07-14 | Carboplatin + Etoposide iv&po | null | null | CARBOPLATIN + ETOPOSIDE | 100824351 |
| 190003536 | 190000550 | 1.8 | 68.2 | null | null | 2018-08-21 | Cisplatin + Gemcitabine (D 1 & 8) | null | null | CISPLATIN + GEMCITABINE | 100902019 |
| 190003548 | 190000552 | null | null | null | 2018-04-21 | 2018-04-21 | Cisplatin + Doxorubicin | 02 | null | CISPLATIN + DOXORUBICIN | 101690038 |
| 190003549 | 190000553 | 1.61 | 57.3 | Disease modification (D) | 2017-04-08 | 2017-04-17 | Carboplatin + Etoposide iv&po | 02 | N | CARBOPLATIN + ETOPOSIDE | 101729980 |
| 190003589 | 190000560 | 1.64 | 60 | Palliative (P) | 2019-09-15 | 2019-09-15 | Cisplatin + Doxorubicin | null | N | CISPLATIN + DOXORUBICIN | 101174992 |
| 190003603 | 190000561 | null | null | null | null | 2018-01-28 | Cisplatin+Gemcitabine (gallbladder) | null | null | CISPLATIN + GEMCITABINE | 100762847 |
| 190003628 | 190000565 | 1.98 | 52.4 | Curative (C) | 2016-07-22 | 2016-07-22 | Cisplatin 7 day | null | Y | CISPLATIN | 101047887 |
| 190003630 | 190000566 | 0 | 40 | Adjuvant (A) | 2016-11-05 | 2016-11-11 | Dox + HD Mtx (post PAM) | 2 | Y | DOXORUBICIN + IFOSFAMIDE | 100146293 |
| 190003632 | 190000568 | null | null | null | null | 2018-03-24 | LU-177 | null | null | PAZOPANIB | 100042531 |
| 190003674 | 190000572 | 1.84 | 58.4 | Palliative (P) | 2016-12-04 | 2016-12-04 | Cisplatin + Radiotherapy | 01 | N | CISPLATIN | 101590290 |
| 190003685 | 190000574 | null | null | null | null | 2016-09-06 | LANREOTIDE | null | null | CARBOPLATIN | 100692129 |
| 190003694 | 190000577 | null | null | null | null | 2017-04-05 | INTERFERON | null | null | OCTREOTIDE | 101623712 |
| 190003699 | 190000578 | null | null | null | null | 2018-06-08 | Cisplatin | null | null | CISPLATIN | 101622676 |
| 190003701 | 190000579 | null | null | null | null | 2017-04-27 | Carboplatin+Fluorouracil 4 or 5 day | null | null | LUTETIUM-177 | 100929414 |
| 190003705 | 190000580 | null | null | null | null | 2018-03-24 | Cisplatin | null | null | OCTREOTIDE | 100230870 |
| 190003722 | 190000583 | 1.66 | 61 | Palliative (P) | 2017-06-16 | 2017-07-05 | Dox + HD Mtx (post PAM) | 02 | N | CARBOPLATIN | 101212500 |
| 190003744 | 190000585 | null | 79 | Palliative (P) | null | 2019-11-05 | Cisplatin + Radiotherapy | null | null | CISPLATIN | 100340951 |
| 190003748 | 190000586 | 1.79 | 82 | Curative (C) | 2018-12-11 | 2018-12-12 | Carboplatin + Paclitaxel (weekly) | N | N | CARBOPLATIN + PACLITAXEL | 101761203 |
| 190003755 | 190000587 | 1.8 | 106 | Palliative (P) | 2019-06-22 | 2019-06-27 | DHAP | 02 | N | SORAFENIB | 101435718 |
| 190003761 | 190000588 | 1.86 | 27.8 | Curative (C) | 2016-03-11 | 2016-03-12 | null | 02 | N | TRIAL | 100358840 |
| 190003787 | 190000592 | 1.77 | 69 | Palliative (P) | 2016-06-03 | 2016-06-03 | Carboplatin + Vinorelbine Oral | 02 | N | LANREOTIDE | 101465638 |
| 190003805 | 190000595 | null | null | null | null | 2016-03-17 | MAP | null | null | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100149881 |
| 190003825 | 190000597 | null | null | null | null | 2016-03-02 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | null | null | OXALIPLATIN + MDG | 101737761 |
| 190003826 | 190000598 | null | null | null | null | 2016-05-16 | Carboplatin + Etoposide iv&po | null | null | CARBOPLATIN + ETOPOSIDE | 100348189 |
| 190003832 | 190000600 | 1.68 | null | Palliative (P) | 2019-12-20 | 2019-12-20 | CARBOPLATIN + RT | 01 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100171864 |
| 190003837 | 190000602 | null | 56 | Adjuvant (A) | 2016-04-14 | 2016-04-29 | CISPLATIN + GEMCITABINE | 02 | null | CISPLATIN + GEMCITABINE | 101452205 |
| 190003841 | 190000603 | null | null | null | null | 2017-06-07 | Dox + HD Mtx (post PAM) | null | null | MITOMYCIN INTRAVESICULAR | 100597789 |
| 190003869 | 190000604 | null | null | null | null | 2016-06-14 | Cisplatin + Radiotherapy | null | null | CISPLATIN | 101835810 |
| 190003874 | 190000605 | 1.8 | 100.9 | Palliative (P) | 2017-09-27 | 2017-10-04 | Cisplatin + Radiotherapy | 02 | N | CISPLATIN | 101045522 |
| 190003884 | 190000607 | null | null | null | 2019-09-18 | 2019-09-20 | ECX | 02 | null | METHOTREXATE + VINBLASTINE | 100868119 |
| 190003944 | 190000611 | 1.6 | 51.6 | Palliative (P) | 2013-04-15 | 2016-12-06 | Bleomycin + Cisplatin + Vinblastine | 02 | N | CAPECITABINE + TEMOZOLOMIDE | 100198332 |
| 190003946 | 190000612 | null | null | null | null | 2019-07-25 | Carboplatin + Etoposide iv&po | null | null | CARBOPLATIN + ETOPOSIDE | 101002227 |
| 190003954 | 190000613 | 1.74 | 97 | Palliative (P) | 2019-07-19 | 2019-07-21 | OST Euramos 1 Closed Trial - Ai | N | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100805621 |
| 190003978 | 190000617 | 1.62 | 50 | Palliative (P) | 2017-12-14 | 2017-12-22 | PAM x 2 post-surgery (cycles 3&4) | 02 | null | FLUOROURACIL + MITOMYCIN + RT | 100250238 |
| 190003985 | 190000619 | 0 | 92.3 | null | 2017-04-08 | 2017-05-27 | EW EuroEwing 2012 Arm A VIDE | 02 | null | DOXORUBICIN + METHOTREXATE | 100284961 |
| 190003994 | 190000621 | 1.6 | 78.5 | null | 2016-05-29 | 2016-06-01 | Carboplatin AUC 2 - 5 | 02 | null | GEMCITABINE | 100452428 |
| 190004004 | 190000622 | 1.83 | 84.9 | Palliative (P) | 2016-05-27 | 2016-05-28 | Cisplatin + Radiotherapy | 02 | null | CISPLATIN | 101431559 |
| 190004005 | 190000623 | 1.84 | 55 | Palliative (P) | 2018-05-17 | 2018-05-23 | CAPECITABINE + MITOMYCIN + RT | 02 | null | DOXORUBICIN | 101581449 |
| 190004018 | 190000626 | 1.49 | 69 | Palliative (P) | null | 2016-03-27 | EURAMOS TRIAL | N | N | CARBOPLATIN | 100809655 |
| 190004032 | 190000628 | null | null | null | null | 2016-11-10 | EW EuroEwing 2012 Arm A VIDE | null | null | PACLITAXEL | 100015020 |
| 190004039 | 190000630 | null | null | null | null | 2018-03-28 | Dox + HD Mtx (post PAM) | null | null | CISPLATIN + FLUOROURACIL + STREPTOZOCIN | 100981080 |
| 190004044 | 190000631 | 1.88 | 65.1 | Adjuvant (A) | 2017-08-17 | 2017-08-20 | CARBOPLATIN + ETOPOSIDE | 02 | N | CARBOPLATIN + ETOPOSIDE | 100075325 |
| 190004081 | 190000636 | null | null | null | null | 2013-09-29 | Bevacizumab 7.5mg/kg | null | null | ECX | 100036226 |
| 190004083 | 190000637 | 1.61 | 68.2 | Adjuvant (A) | 2017-08-13 | 2017-08-25 | Cisplatin | N | N | CISPLATIN | 101801209 |
| 190004119 | 190000641 | null | null | null | null | 2017-09-12 | Dox + HD Mtx (post PAM) | null | null | CARBOPLATIN | 100222999 |